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Current evidences indicate that T cells use protein sorting and degradation to control duration and specificity of T cell receptor (TcR) signalling,
including the CD3~ chain which is ubiquitinated upon TcR triggering. In a previous study, we showed that the Linker of activated T cells (LAT) is
present at the plasma membrane and in transferrin-labelled intracellular compartments also containing the CD3~ chain. Here we show that LAT
protein levels are tightly regulated in Jurkat lymphoid T cells likely involving proteasome-dependent degradation, recycling through trans-Golgi/
endosome compartments and clathrin-dependent internalisation. We further identify a novel post-translational modification of LAT by
ubiquitination that is likely to influence LAT protein stability, intracellular localisation and/or recycling. Our results provide novel molecular and
regulatory insights into the function of LAT adapter protein in T cell signalling.
D 2005 Elsevier B.V. All rights reserved.Keywords: Linker of activated T cell; Ubiquitination; Adapter protein complex; T cell signalling; Intracellular trafficking1. Introduction
Activation of T lymphocytes is a tightly controlled, dynamic
process initiated by the binding of antigenic peptides presented
by major histocompatibility complexes on the antigen present-
ing cells to the T cell receptor (TcR). Soon upon activation, the
TcR, coreceptors, adhesion molecules and signalling and
cytoskeletal components accumulate and segregate into supra-
molecular clusters at the T cell-antigen presenting cell
interface: the immune synapse [1,2]. This subcellular redistri-
bution of molecules involves both centrifuge and centripetal
fluxes between the plasma membrane and intracellular com-
partments (for a review, see [3]). While the TcR accumulates at
the immune synapse through lateral movements along the
plasma membrane, it is also continuously internalised and
recycled back to the cell surface by polarised recruitment from
endosomal compartments [4,5]. In the mean time of T cell
activation, the TcR is down-regulated which appears to result
from increased retention and or degradation of internalised
molecules [4] and has been proposed as one mechanism that0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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1 These authors equally contributed to the work.terminates signalling [6]. Among several potential pathways
leading to TcR down-regulation, ubiquitin conjugation to TcR
sub-units, and particularly the CD3~ chain, has been shown in
activated T cells [7,8] and appears to be promoted by the E3
ubiquitin ligase Cbl through the adapter function of the tyrosine
kinase ZAP-70 [9]. Other essential components of the TcR
signalling machinery also appear to cycle along endosomal
compartments and to be polarised and recruited towards the
immune synapse upon T cell activation [5,10,11].
Among them is the adapter protein LAT, an integral
membrane protein which cytoplasmic tail contains several
tyrosine phosphorylation motifs. Once phosphorylated by
ZAP-70, these motifs recruit Src homology 2 (SH2) domain-
containing enzymes and enzyme–adaptor complexes. Thus,
LAT may serve as a scaffold protein that orchestrates signalling
pathways that are strictly required for T cell activation [12].
The essential role of LAT in T cell activation and development
is underscored by studies performed on LAT deficient cells and
knock out mice showing impaired TcR signalling [13,14] and
T-cell development [15], respectively. In a previous study, we
showed that LAT forms two distinct cellular pools, one at the
plasma membrane and one that co-distributed with transferrin-
labelled intracellular compartments also containing the CD3~
chain [11]. The distribution of LAT between these two pools1746 (2005) 108 – 115
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cytoplasmic C-terminus amino acid residues were required for
its own recruitment to the immune synapse and a juxta-
membrane LAT region (amino acid 32–104) was involved in
the localisation of LAT in this intra-cellular pool and in T-cell
signalling. But whether LAT, which co-localises with the CD3~
chain in endosomal compartments, is similarly down-regulated
and/or recycled, and the molecular determinants controlling
these events remains unknown.
2. Material and methods
2.1. Cells and reagents
The Jurkat JA16 T cells and COS-7 cells were cultured in RPMI and
DMEM supplemented with 10% FCS, respectively.
2.2. Plasmid constructs
LAT-, LATDCt- and LATD32-104-GFP constructs were previously described
[11]. Myc-LAT was obtained by PCR amplification using LAT cDNA and the
following primer pairs: 5VcaagcttatggaacaaaaattaatttctgaagaagaucttaatatQ
ggaagcagacgccttgagcccggtggggctgggcctg and 3V-gagaatctgcaggagcttaac-
tgaggatcc followed by successive cloning in pGEMT-easy (Promega, France)
and pCDNA3 (Invitrogen, France). The HA-ubiquitin construct was a kind
gift from JR Courbard (UMR 599 INSERM, Marseille, France). The Fyn con-
struct was a kind gift from D. Davidson (Institut de Recherches Cliniques
de Montre´al, Que´bec, Canada).
2.3. Transfection, immunoprecipitation and immunoblotting
COS-7 cells were transfected using Fugene 6, as recommended by the
manufacturer (Roche, France). Briefly, 6-well plates were seeded with cells
and 70% confluent cell cultures were used for transfection. Cells were co-
transfected with Fyn (0.5 Ag), Myc-LAT (0.5 Ag) or LAT-GFP (0.5 Ag)
constructs together with HA-ubiquitin plasmid (0.5 Ag). 24 H after
transfection, cells were lysed using either NP-40 cell lysis buffer (50 mM
Tris H 7.4; 150 mM NaCl; 5 mM EDTA; 5 mM EGTA; 50 mM NaF; 1% NP-
40) or RIPA buffer (50 mM Tris H 7.4; 150 mM NaCl; 5 mM EDTA; 5 mM
EGTA; 50 mM NaF; 1% Triton-X100; 0.1% SDS; 1% DOC) and cellular
lysates were subjected to immunoprecipitation using anti-Myc 9E10 mono-
clonal antibody (Santa Cruz, TEBU, France), anti-GFP polyclonal antibody
(Abcam, UK), anti-Fyn polyclonal antibody (Santa Cruz, TEBU, France), or
anti-LAT polyclonal antibody (Upstate Biotechnology, Euromedex, France) as
described [16]. After extensive washing, immunoprecipitates were analysed by
immunoblotting using anti-HA 3F10 monoclonal antibody (Roche, France),
anti-Fyn monoclonal antibody (Santa Cruz, TEBU, France), anti-GFP
monoclonal antibody (Roche, France) or anti-LAT monoclonal antibody
(Upstate Biotechnology, Euromedex, France) followed by enhanced chemilu-
minescence (West Pico, Pierce, France).
Jurkat cells were left untreated or treated with MG132 (Calbiochem, 50
AM), and/or chlorpromazine (Calbiochem, 20 AM), as indicated in figure
legends. For TcR activation, cells were incubated in culture medium in the
presence of CD3 monoclonal antibody (289, 5–10 Ag/ml) for 10 min at room
temperature followed by CD3 antibody cross-linking in the presence of goat
anti-mouse antibody (2.5–5 Ag/ml) for 5 to 60 min at 37 -C, as indicated in
figure legends. Cell activation was stopped by transferring cells on ice followed
by lysis using NP-40 or RIPA cell lysis buffers, and immunoprecipitation with
LAT polyclonal antibody (Upstate Biotechnology, Euromedex, France) or Fyn
polyclonal antibody (Santa Cruz, TEBU, France). Immunoprecipitates were
analysed by immunoblotting using anti-ubiquitin P4D1 monoclonal antibody
(Cell Signalling Technology, France), anti-LAT monoclonal antibody (Upstate
Biotechnology, Euromedex, France) or anti-Fyn monoclonal antibody (Santa
Cruz, TEBU, France) followed by enhanced chemiluminescence (West Pico,
Pierce, France).2.4. Immunofluorescence
Immunofluorescence experiments were performed on Jurkat cells, as
described [11]. For TcR activation, cells were incubated in culture medium
in the presence of CD3 monoclonal antibody (289, 10 Ag/ml) for 10 min at
room temperature followed by CD3 antibody cross-linking in the presence of
goat anti-mouse antibody (5 Ag/ml) for 15 min at 37 -C. Images were acquired
using a Leica TCS SP2 confocal scanning microscope equipped with a 100x
1.4 NA HCX PL APO oil immersion objective, Ar and HeNe lasers emitting at
488 and 543 nm respectively. Double staining images were obtained at zoom 4,
with the intensity of excitation wavelengths and the power of photodetectors
adjusted to avoid cross-talk. On a medial Z-section, fluorescence intensity was
measured within regions encompassing the intracellular pool or total LAT. Anti-
a, -h and -g adaptins and anti-cis-Golgi p130 monoclonal antibodies were from
BD Transduction laboratories (France). The anti-PACS-1 goat polyclonal
antibody was from (Santa Cruz, TEBU, France).3. Results
Because ubiquitin carries an endocytosis signal and can
target the degradation of proteins, we first attempted to
determine whether LAT could be ubiquitinated. Jurkat T cells
were treated in the presence of the proteasome inhibitor
MG132 followed by cell lysis using NP-40 as detergent, LAT
protein immunoprecipitation and anti-ubiquitin western blot-
ting. Whereas no ubiquitinated proteins could be detected
upon LAT immunoprecipitation from untreated Jurkat cells, a
time-dependent accumulation of anti-ubiquitin reactive pro-
teins co-immunoprecipitated with the LAT antibody, seen as
distinct higher-molecular-weight species together with a smear
(Fig. 1A, upper panel). Yet, anti-LAT immunoblotting did not
reveal the higher-molecular-weight species and smear to be
LAT, a parallel increase of LAT levels was clearly evidenced
(Fig. 1A, lower panel), consistent with a block of proteasome-
dependent degradation of ubiquitinated LAT. Although LAT
was not reported so far to interact with cellular proteins in
quiescent lymphocytes, it was difficult to exclude that the
higher-molecular-weight species detected by anti-ubiquitin
western blotting corresponded to ubiquitinated proteins
distinct from LAT and co-immunoprecipitated together with
LAT. To help resolve this possibility, cell lysates were
prepared using SDS together with NP-40 and DOC as
detergents (RIPA buffer), which has the potential to disrupt
protein:protein interactions while leaving intact ubiquitin
moieties, which are covalently linked to their target. Similarly
to the results obtained using NP-40 detergent-based lysis
buffer, higher-molecular-weight species were detected by anti-
ubiquitin blotting of LAT immunoprecipitates derived from
RIPA buffer cell lysates obtained from MG132 treated but not
untreated Jurkat cells (Fig. 1B). Again, anti-LAT immuno-
blotting failed to reveal the higher-molecular-weight species
to be LAT (Fig. 1B), even upon long film exposure (not
shown). Notably, similar results were obtained with anti-Fyn
immunoprecipitates, a well-known ubiquitinated Src family
kinase [17].
To document further LAT ubiquitination, COS-7 cells were
co-transfected with myc- and GFP-tagged LAT encoding
constructs together with a HA-tagged ubiquitin encoding
plasmid. As a positive control in this assay, a plasmid
Fig. 1. Ubiquitination of LAT in Jurkat lymphoid T cells. (A) Jurkat T cell cultures (107) were left untreated () or incubated in the presence of MG132 (50 AM) for
the indicated time, followed by cell lysis in the presence of 1% NP-40 and LAT immunoprecipitation using rabbit polyclonal antibody. LAT immunoprecipitates were
resolved by SDS-PAGE followed by immunoblotting using the anti-ubiquitin mouse monoclonal antibody (upper panel) or the rabbit polyclonal anti-LAT antibody
(lower panel). (B) Jurkat T cell cultures (107) were left untreated () or incubated for 4 H in the presence of MG132 (50 AM), followed by cell lysis using RIPA
buffer (see materials and methods) and immunoprecipitation using either LAT or Fyn rabbit polyclonal antibodies, as indicated. Immunoprecipitates were resolved by
SDS-PAGE followed by immunoblotting using the anti-ubiquitin, anti-LAT or anti-Fyn mouse monoclonal antibodies, as indicated. Ig, immunoglobulins from
antibodies used for immunoprecipitation; (Ub)n, poly-ubiquitinated proteins.
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sion, Fyn and LAT proteins were immunoprecipitated and
analyzed by anti-HA immunoblotting (Fig. 2, upper panels) to
examine for the transfer of HA-ubiquitin on these proteins,
and Fyn (not shown) or LAT (Fig. 2, lower panels)
immunoblotting to check for proper expression of these
proteins. As expected, immunoprecipitated Fyn displayed
high anti-HA reactivity upon co-expression with the HA-
tagged ubiquitin encoding plasmid, yielding a ladder of
reactive bands which is indicative of polyubiquitination
(Fig. 2, upper panel). Similarly, immunoprecipitated LAT
displayed anti-HA reactivity, producing a ladder of reactiveFig. 2. Ubiquitination of LAT in transfected COS-7 cells. COS-7 cells were
transfected with plasmid constructs encoding for Fyn (lanes 3, 4), myc-LAT
(lanes 7, 8) or LAT-GFP (lanes 11, 12) and HA-ubiquitin (, +). Empty
plasmid constructs were included as control (lanes 1, 2, 5, 6, 9, 10). 24 h after
transfection, cells were lysed followed by immunoprecipitation using either
anti-Fyn or anti-GFP rabbit polyclonal antibodies, or anti-Myc mouse
monoclonal antibody, as indicated. Immunoprecipitates were resolved by
SDS-PAGE followed by immunoblotting using anti-HA mouse monoclonal
(upper panels) and anti-LAT rabbit polyclonal (lower panels) antibodies. Ig,
immunoglobulins from antibodies used for immunoprecipitation.bands, in both myc- and GFP-tagged LAT immunoprecipi-
tates, indicating that ubiquitination of LAT was independent
of the tag used for immunoprecipitation. The pattern
detected in anti-Myc immunoprecipitates clearly differed
from that seen in anti-GFP immunoprecipitates, indicating
that anti-HA reactive species did not corresponded to co-
immunoprecipitated cellular proteins, but rather reflected the
distinct molecular weight of Myc- versus GFP-tagged LAT.
As a negative control, LAT or Fyn showed no anti-HA
reactivity in cells transfected with empty vectors instead of
the HA-tagged ubiquitin encoding plasmid.
Ubiquitination of a protein substrate occurs via a
covalent isopeptide bond formation between the C-terminal
glycine of ubiquitin and the (-amino group of lysine
residues of the substrate. LAT contains two lysine residues
(K53 and K121 in Fig. 3A) each included in LAT protein
domains that we have characterised in a previous study and
the deletion of which alter the sub-cellular distribution of
LAT between the plasma membrane and an intra-cellular
compartment labelled by transferin [11]. While GFP-LAT
deleted of amino acid 32–104 (LATD32–104) essentially
displayed plasma membrane versus low intra-cellular stain-
ing, the GFP-LAT construct deleted of its C-terminus
beginning at amino acid 104 (LATDCter) showed high
intra-cellular versus low plasma membrane staining [11]. We
thus used these LAT constructs to determine the implication
of each protein domain in LAT ubiquitination in the assay
describe above. Strikingly, while LATD32–104 immunopre-
cipitates displayed strong anti-HA reactivity, LATDCter
showed only barely detectable reactivity (Fig. 3B upper
panel), despite reproducibly (not shown) higher levels of
expression of LATDCter and lower levels of LATD32–104
compared to the full length LAT construct (Fig. 3B, lower
panel). These experiments identify a requirement for LAT c-
terminus in LAT ubiquitination, since deletion of amino acid
32–104 only moderately effect on LAT ubiquitination while
deletion of the LAT c-terminus abolishes most of LAT
ubiquitination.
Fig. 3. Ubiquitination of LAT requires LAT c-terminus but not LAT 32–104 amino acid residues. (A) Primary sequences of murine LAT. Amino acid residues deleted
in LATD32–104 and LATDCter constructs are boxed or underlined, respectively. The putative ubiquitinated lysine residues as well as putative sorting signals (see
text) are marked as bold characters. (B) Ubiquitination of LAT deletion constructs. Plasmid constructs encoding for GFP fused to full length LAT (WT), LATD32–
104 (D32–104) and LATDCter (DCter) were analysed as described in Fig. 2, except that anti-GFP immunoprecipitates were analysed by immunoblotting using the
anti-HA mouse monoclonal antibody and the anti-GFP rabbit polyclonal antibody. Ig, immunoglobulins from antibodies used for immunoprecipitation. (C) As in B,
except that cell lysis was performed using RIPA buffer, as described in Materials and methods, and that anti-GFP immunoblotting was performed using the anti-GFP
mouse monoclonal antibody.
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brane compartments by serving as a sorting signal on protein
cargo we next performed co-labelling experiments using
antibodies recognising adapter proteins (AP) involved in
protein trafficking between intracellular compartments. Using
human Jurkat T lymphocytes expressing endogenous LAT to
perform immunofluorescence experiments, a clear co-labelling
of LAT with g adaptin specific of AP1 complexes and with
phosphofurin acidic cluster sorting protein 1 (PACS-1) was
detected, while staining with a adaptin (AP2 complexes) and
with the p130 Cis-Golgi marker showed absence of significant
co-localisation (Fig. 4). Labelling with antibodies recognising
h adaptin present in AP1–4 complexes revealed only partial
co-localisation, which was consistent with the co-staining with
g but not with a adaptin (Fig. 4). Collectively with our
previous study [11], these experiments are in support of the
hypothesis that LAT is sorted along endosomes and trans-
Golgi Network (TGN) compartments, and are consistent with a
putative regulatory role of ubiquitin in this transport of LAT.
Many growth factor receptors undergo ligand-stimulated
ubiquitination, including the T cell receptor, and this modifi-
cation appears to control both internalisation and subsequent
endosomal sorting which can either be followed by recycling or
targeting to degradation in lysosomes or the proteasome-
mediated pathway. To evaluate the possibility that LAT is
down-regulated upon T cell receptor stimulation, Jurkat T cells
were stimulated for 60 min by CD3 cross-linking followed by
co-labelling experiments using anti-AP2 and -LAT antibodies
(Fig. 5A). In contrast to unstimulated Jurkat cells where LAT-
and AP2-labelled compartments were clearly distinct (Figs. 4
and 5A), a large intracellular compartments was co-labelled by
anti-AP2 and -LAT antibodies in CD3 stimulated cells (Fig.5A). Time-course western blotting experiments performed on
CD3 cross-linked Jurkat cells evidenced a parallel increase of
LAT levels, as compared to tubulin a (Fig. 5B) or actine (not
shown), whereas LAT levels remain stable in unstimulated
cells. In parallel, cells were treated in the presence of
chlorpromazine followed by CD3 cross-linking and western
blotting. A striking decrease of LAT levels was observed over
the time-course experiment, indicating the requirement for
clathrin-dependent internalisation of cell-surface molecules,
including LAT and CD3, for CD3-induced LAT accumulation
(Fig. 5B). MG132 treatment prevented CD3-stimulated LAT
increase, yet maintained steady state levels of LAT,
indicating that CD3-induced LAT accumulation involves a
proteasome-dependent event. To examine how ubiquitination
might relate to LAT turnover, lysates from CD3-stimulated
cells were immunoprecipitated using LAT antibody followed
by anti-ubiquitin western blotting. As compared to unstimu-
lated cells, CD3 cross-linking induced barely detectable
higher-molecular-weight species together with a smear, which
was better evidenced upon chlorpromazine and MG132
treatment of cell cultures and correlated with increased
LAT levels (Fig. 5C).
4. Discussion
The present study provides strong evidences that LAT is a
target for ubiquitination in Jurkat T cells and that this
modification may contribute a regulated signal involved either
in LAT intracellular traffic and degradation. The conclusion
that LAT is ubiquitinated was drawn from the combined
following observations. First, LAT immunoprecipitation from
Jurkat cells yielded higher-molecular-weight reactivity in anti-
Fig. 4. Immunofluorescence analysis of LAT co-staining with adapter proteins involved in endosome-TGN protein sorting. Jurkat T cells were labelled with anti-LAT
(red) and either anti-PACS1, anti-p130, anti-adaptin a, h or g (green), antibodies, as indicated. Shown are single-colour or two-colour overlay (merge) images
acquired with a confocal microscope at a medial Z-section. Enlargement of one representative cell from the two-colour overlay image is shown on the right.
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dependent on the inhibition of the proteasome activity and
accordingly correlated with increased LAT levels. Second, LAT
was found ubiquitinated in heterologous COS-7 cells using a
HA-ubiquitin transfer assay. Although we cannot definitively
exclude that the higher-molecular-weight reactive proteins are
ubiquitinated, co-immunoprecipitated proteins distinct from
LAT, the corresponding signal resisted detergent conditions
disrupting non-covalent protein:protein interactions (RIPA
buffer). Third, in COS-7 cells, the ubiquitination pattern was
distinct using myc-tagged and GFP-tagged LAT, and required
LAT c-terminus, indicating that the corresponding ubiquiti-
nated proteins are essentially LAT constructs and not associated
proteins. LAT contains two putative ubiquitination target sites,
K53 and K121. The deletion of amino acid 32–104 containing
the lysine residue K53 did not significantly alter LAT
ubiquitination in our ubiquitin transfer assay, suggesting that
only one lysine residue, K121, can be targeted for ubiquitina-tion. Site-directed mutagenesis experiments will be required to
verify this hypothesis.
The best-characterised function of ubiquitin is to target
substrate proteins for degradation in the proteasome. However,
ubiquitin modification is also emerging as a signal that targets
plasma membrane proteins for destruction in vacuoles and/or
lysosomes, and other functions in endosomal sorting, regula-
tion of translation, activation of transcription factors and
kinases and DNA repair (for a review, see [18]). Using
MG132 as an inhibitor of the proteasome, a time-course-
dependent accumulation of anti-ubiquitin antibody reactive
LAT was detected in Jurkat lymphoid T cells analysed by
western blotting, forming a ladder of reactive bands that is
typical of poly-ubiquitination. The poly-ubiquitination of LAT
can provide a homeostatic control of LAT cellular levels,
particularly at the plasma membrane, which might be important
to avoid hyper-reactivity of T cells. Indeed, CD3 cross-linking
induced higher-molecular-weight anti-ubiquitin reactivity of
Fig. 5. Regulation of LAT in stimulated Jurkat T cells. (A) Jurkat cells were left unstimulated (mock) or were stimulated for 60 min by CD3 cross-linking (CD3)
followed by co-staining using LAT (red) and anti-adaptin a (green) antibodies, as described in Fig. 4. (B) Jurkat cells were left unstimulated () or were stimulated
by CD3 cross-linking (CD3) for the indicated time, in the presence of chlorpromazine (CZ) or MG132 (MG), as indicated. After stimulation, cell lysates were
directly resolved by SDS-PAGE followed by anti-LAT and anti-a tubulin immunoblotting, as indicated. A quantification of the results shown in B by using
densitometry is shown after normalisation of LAT signals to a tubulin signals (lower panel). (C) Jurkat cells were left unstimulated () or were stimulated for 60 min
by CD3 cross-linking (CD3) in the presence of chlorpromazine (CZ) or MG132 (MG), as indicated, followed by cell lysis using RIPA buffer and LAT
immunoprecipitation. Immunoprecipitates were resolved by SDS-PAGE followed by anti-ubiquitin (upper panel). Total cell lysates were immunoblotted in parallel,
using anti-LAT and anti-tubulin a mouse monoclonal antibodies, as indicated. A quantification of the results was obtained by using densitometry and is shown below
the blot as LAT signals normalised to tubulin a signals. AU, Arbitrary unit.
C. Brignatz et al. / Biochimica et Biophysica Acta 1746 (2005) 108–115 113LAT immunoprecipitates that was best evidenced upon
inhibition of both the proteasome activity and clathrin-
dependent internalisation of cell surface proteins, yielding an
increase of LAT level. Ubiquitination of LAT, similarly to the
CD3~ chain, might be targeted to the lysosomal and/or
proteasome degradation pathway, which has been suggested
to resolve T cell activation [3,4,19]. Given the essential role of
adapter protein played by LAT in TcR signalling, through
tyrosine phosphorylation-dependent recruitment of signalling
molecules, the internalisation and subsequent degradation of
‘‘activated’’ LAT signalling complexes might be more efficient
than the dephosporylation of each tyrosine residue and/or the
degradation of each binding partner. However, CD3 cross-
linking induced LAT accumulation in Jurkat cells and
treatment with chlorpromazine, an inhibitor of clathrin-
mediated cell surface protein internalisation, prevented CD3-
induced LAT accumulation and was even associated with
reduced LAT levels as compared to unstimulated cells. This
result suggests that upon T cell activation, internalisation of
LAT or other cell surface protein(s) might override and/or
prevent LAT degradation. Consistent with this hypothesis,
CD3 cross-linking induced the recruitment of LAT to AP-2-
labelled compartments, a target of chlorpromazine action [20].That LAT was degraded following CD3 stimulation upon
chlorpromazine treatment implies protein degradation to occur
before or independently of LAT internalisation, as shown for
agonist-induced glutamate receptor internalisation in hippo-
campal neurons [21]. A clathrin-independent pathway might
also be involved, such as the non-classical endocytic pathway
sensitive to cholesterol depletion, which is consistent with
LAT being a lipid-raft resident component [22]. Of interest,
cell-surface TGFhRs are subjected to a dynamic compart-
mentalization between raft and non-raft membranes, and can
traffic through distinct clathrin-dependent and clathrin-inde-
pendent endocytic routes that regulate TGFhRs signalling and
degradation, respectively [23]. Blocking clathrin-dependent
internalisation upon T cell activation would thus favour LAT
degradation, possibly through polyubiquitination and/or inter-
nalisation via a clathrin-independent degradative pathway.
Indeed, combination of chlorpromazine treatment with protea-
some inhibition by using MG132 induced high accumulation
of LAT in CD3-stimulated cells (Fig. 5C), indicating that LAT
degradation induced by chlorpromazine involved a protea-
some dependent pathway. Further experiments will be
required to establish the pathway and effectors involved in
CD3-regulated LAT levels.
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endosomal sorting of ligand-stimulated receptors (for a review,
see [18,24]), and very recently, the Golgi-associated, g-adaptin
homologues, Arf-binding (GGA) proteins were also shown to
bind ubiquitin directly and to be necessary for the delivery of
endosomal cargoes from the TGN [25,26]. In a previous study
we identified an intra-cellular compartment containing accu-
mulated LAT protein and provided a preliminary description of
this compartment that co-localised with labelled transferin and
CD3~ , indicating that LAT can cycle through the endocytic
pathway [11]. Amino acid 32–104-deleted LAT accumulated at
the plasma membrane whereas c-terminus-deleted LAT accu-
mulated within this compartment, suggesting that these two
regions contain internalisation and/or sorting signals. In the
present study, we further documented this compartment.
Consistent with the hypothesis that ubiquitination of LAT can
provide a signal for intracellular trafficking, we show a co-
staining of LAT compartment with g-adaptin and PACS-1, two
adaptor proteins involved in protein trafficking between the
TGN and endosomes [27,28]. In addition to residues K53 and
K121, analysis of the LAT primary sequences reveals several
sorting and/or internalisation signals recognised by the hetero-
tetrameric AP complexes AP1-4 (Y67xxV, L81L82) or by
PACS-1, (D126EDEDD, E180SEESAE, E219DEGEEE), and
present in a broad range of secretory pathway membrane
proteins (Fig. 3A). It is tempting to speculate that LAT,
similarly to CD3~ , is continuously internalised and recycled
back to the cell membrane. This would allow to constitute an
intra-cellular pool of sorted molecules and to control the level
of plasma membrane-associated LAT. Upon T cell activation,
this routing might be altered, allowing accumulation and
recruitment of internalised LAT to the immune synapse to
sustain and/or to amplify activation. The ubiquitination of LAT
described herein might thus provide important regulatory
signals in these processes. Future studies will aim to target
each of the putative LAT sorting signals by systematic
mutagenesis experiments and to examine for their respective
role in LAT sub-cellular distribution, trafficking and interac-
tions with candidate adapter proteins. Mutagenesis of K121
residue as candidate LAT ubiquitination site will also be
performed to discriminate between the role of LAT c-terminus
bearing the LAT ubiquitination site (K121) versus an ubiquitin
ligase binding domain. These experiments will be of impor-
tance to uncover the role of LAT ubiquitination in the
regulation of T cell activation, and more generally, the function
of LAT in T cells.
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